Skin Neoplasms: all 591 studies
Page 2 of 6. Open to participants first (115), then studies with results posted, then the rest; newest registration first within each.
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaRecruitingNCT04534127Not applicable
- Intratumoral Administration of Daromun in Non-melanoma Skin Cancer PatientsRecruitingNCT04362722Phase 2
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
- Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityRecruitingNCT04273061Phase 2
- Nivolumab for Treatment of Squamous Cell Carcinoma of the SkinRecruitingNCT04204837Phase 2
- DNA Repair Activity in the Skin of Day and Night Shift WorkersRecruitingNCT04122456Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous TumorsRecruitingNCT04068155Not applicable
- Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted AngiomaRecruitingNCT04056962Phase 2
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.RecruitingNCT03889899Not applicable
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous MelanomaRecruitingNCT03860883Not applicable
- Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer SurgeryEnrolling by invitationNCT03503240
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of PembrolizumabRecruitingNCT02621021Phase 2
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of MelanomaRecruitingNCT00040352
- Sun Protection and Tanning Awareness in Rural SchoolsCompletedNCT06694571Not applicableResults posted
- Virtual Sun Safe Workplaces Ph II (SSW Works)CompletedNCT05774600Not applicableResults posted
- Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) SunscreenCompletedNCT05736224Phase 1Results posted
- Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum OintmentCompletedNCT05618912Not applicableResults posted
- At-Home Dermoscopy Artificial IntelligenceTerminatedNCT05321784Not applicableResults posted
- Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBxCompletedNCT05257486Results posted
- Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous MelanomaTerminatedNCT05200143Phase 2Results posted
- Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaCompletedNCT05188729Phase 2Results posted
- Incidence of Melanoma and Non-melanoma Skin Cancer in People With VitiligoCompletedNCT04969419Results posted
- IFx-Hu2.0 for the Treatment of Patients With Skin CancerCompletedNCT04925713Phase 1Results posted
- Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell CarcinomaActive, not recruitingNCT04869137Phase 2Results posted
- Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma PatientsCompletedNCT04526730Phase 2Results posted
- SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin CancerCompletedNCT04411810Not applicableResults posted
- A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic MelanomaTerminatedNCT04337931Phase 2Results posted
- Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D MelanomaTerminatedNCT04310397Phase 2Results posted
- Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCCompletedNCT03989115Phase 1/2Results posted
- Risk Information and Skin-cancer Education for Undergraduate PreventionCompletedNCT03979872Not applicableResults posted
- Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell CancerActive, not recruitingNCT03944941Phase 2Results posted
- Social Media Indoor Tanning StudyCompletedNCT03834974Not applicableResults posted
- ObservAtional Study to Investigate Surgical Site Infection in Ulcerated Skin CancersCompletedNCT03782727Results posted
- Study of TVEC in Patients With Cutaneous Squamous Cell CancerCompletedNCT03714828Phase 2Results posted
- A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)CompletedNCT03693937Results posted
- pDNA Intralesional Cancer Vaccine for Cutaneous MelanomaCompletedNCT03655756Early Phase 1Results posted
- Using MC1R Genotype to Impact Melanoma Risk BehaviorCompletedNCT03509467Not applicableResults posted
- Prostaglandin Inhibition and Immune Checkpoint Blockade in MelanomaCompletedNCT03396952Phase 2Results posted
- Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable MelanomaTerminatedNCT03325101Phase 1/2Results posted
- Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet ExposureCompletedNCT03315286Not applicableResults posted
- Strategies to Promote Skin HealthCompletedNCT03237013Not applicableResults posted
- Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaCompletedNCT03229278Phase 1Results posted
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
- Preoperative Acetaminophen and Carbohydrate LoadingCompletedNCT03131713Phase 3Results posted
- Study of Topical SOR007 Ointment for Cutaneous MetastasesCompletedNCT03101358Phase 1/2Results posted
- Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell CarcinomaActive, not recruitingNCT03071406Phase 2Results posted
- Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced MelanomaCompletedNCT03033576Phase 2Results posted
- Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.CompletedNCT03024866Results posted
- A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced MelanomaTerminatedNCT02967692Phase 3Results posted
- Randomized Comparison of Low and Conventional Irradiance PDT for Skin CancerCompletedNCT02872909Not applicableResults posted
- Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers Phase ICompletedNCT02824289Not applicableResults posted
- Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV MelanomaTerminatedNCT02748564Phase 2Results posted
- 5-fluorouracil Versus Placebo in Periocular Full Thickness Skin GraftsCompletedNCT02705352Phase 2Results posted
- Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin LesionsCompletedNCT02704104Not applicableResults posted
- Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerCompletedNCT02595866Phase 1Results posted
- Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV MelanomaTerminatedNCT02587650Phase 2Results posted
- Neoadjuvant and Adjuvant Checkpoint BlockadeCompletedNCT02519322Phase 2Results posted
- Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic MelanomaCompletedNCT02500576Phase 2Results posted
- Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin CancerCompletedNCT02324608Not applicableResults posted
- Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasCompletedNCT02304458Phase 1/2Results posted
- Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell CarcinomaTerminatedNCT02303041Phase 2Results posted
- PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous MelanomaTerminatedNCT02288897Phase 3Results posted
- Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell CarcinomaCompletedNCT02218164Phase 2Results posted
- Post Excision/Mohs Scar Laser ResurfacingCompletedNCT02130297Not applicableResults posted
- A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV MelanomaCompletedNCT02129075Phase 2Results posted
- Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaTerminatedNCT02111863Phase 2Results posted
- Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryTerminatedNCT02097225Phase 1Results posted
- Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive MelanomaCompletedNCT02083354Phase 2Results posted
- Cabozantinib in Recurrent/Metastatic Merkel Cell CarcinomaTerminatedNCT02036476Phase 2Results posted
- Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)TerminatedNCT01984892Phase 2Results posted
- Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV MelanomaCompletedNCT01961115Phase 2Results posted
- Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant MelanomaCompletedNCT01909453Phase 3Results posted
- Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV CancerCompletedNCT01902173Phase 1/2Results posted
- Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by SurgeryCompletedNCT01886235Not applicableResults posted
- Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell CarcinomaCompletedNCT01835626Phase 2Results posted
- Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the SkinTerminatedNCT01823679Phase 2Results posted
- Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic MelanomaCompletedNCT01807182Phase 2Results posted
- Sirolimus in Kidney Transplant Patients With Squamous Cell Skin CarcinomaTerminatedNCT01764607Phase 2Results posted
- Vitamin D Supplementation in Cutaneous Malignant Melanoma OutcomeCompletedNCT01748448Phase 3Results posted
- Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic MelanomaCompletedNCT01740557Phase 1/2Results posted
- Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets PtsCompletedNCT01701674Not applicableResults posted
- Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous MelanomaCompletedNCT01693068Phase 2Results posted
- An Appearance-Based Intervention to Reduce Teen Skin Cancer RiskCompletedNCT01508013Not applicableResults posted
- Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor CellsTerminatedNCT01495572Phase 2Results posted
- Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009gCompletedNCT01480219Results posted
- Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaTerminatedNCT01468818Phase 2Results posted
- Recombinant Interferon Alfa-2b in Treating Patients With MelanomaCompletedNCT01460875Not applicableResults posted
- Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin CancerTerminatedNCT01459666Phase 4Results posted
- Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic MelanomaTerminatedNCT01369888Phase 1/2Results posted
- Modified Tumor Infiltrating Lymphocytes for Metastatic MelanomaTerminatedNCT01369875Phase 2Results posted
- Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery PatientsCompletedNCT01359735Phase 2Results posted
- Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...CompletedNCT01319565Phase 2Results posted
- Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT01258855Phase 2Results posted
- A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell CancerCompletedNCT01130519Phase 2Results posted
- Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...CompletedNCT01118091Phase 2Results posted
- Can We Miss Pigmented Lesions in Psoriasis Patients?CompletedNCT01053819Phase 4Results posted
- Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic MelanomaCompletedNCT00885534Phase 2Results posted
- Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive ProtocolTerminatedNCT00866684Phase 4Results posted